Bluebook
Diagnostics & Tools April 2022
2022 - April: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Groupe Bruxelles Lambert (GBL) has agreed to acquire Affidea for approximately $1bb
- bioMérieux has agreed to acquire Specific Diagnostics for $391mm
- Castle Biosciences has acquired AltheaDx for $140mm